FDA recall Z-0567-2022

Mallinckrodt Pharmaceuticals Ireland Ltd · Class II · device

Product

THERAKOS CELLEX Photopheresis Procedural Kit, CLXUSA

Reason for recall

This recall was initiated to recover a Dunnage Case, which is a case of three (3) CLXUSA kits. This Dunnage Case was shipped on 02-Dec-2021. Dunnage is used during the sterilization process and is not intended for customer use.

Distribution

US Nationwide distribution in the states of CA, FL, GA, MA, MI, NC, NJ, NY, OH, TN, TX, VA, WV.

Key facts

Status
Ongoing
Initiation date
2021-12-10
Report date
2022-02-16
Voluntary/Mandated
Voluntary: Firm initiated
Location
Dublin 15, N/A, Ireland

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0567-2022